Cardiac amyloidosis secondary prevention: Difference between revisions
Jump to navigation
Jump to search
m (Bot: Adding CME Category::Cardiology) |
No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Cardiac amyloidosis}} | {{Cardiac amyloidosis}} | ||
{{CMG}} | |||
==Overview== | |||
There are no established measures for the primary prevention of cardiac amyloidosis. | |||
==Secondary Prevention== | |||
There are no established measures for the secondary prevention of cardiac amyloidosis. | |||
==References== | ==References== | ||
{{ | {{reflist|2}} | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
Line 11: | Line 16: | ||
[[CME Category::Cardiology]] | [[CME Category::Cardiology]] | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Cardiology]] | [[Category:Cardiology]] | ||
[[Category:Rheumatology]] | [[Category:Rheumatology]] |
Latest revision as of 15:24, 7 November 2019
Cardiac amyloidosis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Cardiac amyloidosis secondary prevention On the Web |
American Roentgen Ray Society Images of Cardiac amyloidosis secondary prevention |
Risk calculators and risk factors for Cardiac amyloidosis secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
There are no established measures for the primary prevention of cardiac amyloidosis.
Secondary Prevention
There are no established measures for the secondary prevention of cardiac amyloidosis.